[Long term effects of the beta-adrenergic blocking agent atenolol (Tenormin) on coronary heart disease: a study of 125 patients (author's transl)].
D000328:Adult; D000368:Aged; D001262:Atenolol / Q000008:administration & dosage / Q000627:therapeutic use*; D001794:Blood Pressure; D003327:Coronary Disease / Q000188:drug therapy*; D004341:Drug Evaluation; D005080:Exercise Test; D005260:Female; D006339:Heart Rate; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D011412:Propanolamines / Q000627:therapeutic use*
D011412:Propanolamines; D001262:Atenolol
Langzeitwirkung des Betarezeptorenblockers Atenolol (Tenormin) bei koronarer Herzkrankheit: Eine Untersuchung an 125 Patienten.